Outbreak of acinetobacter infection in extremely low birth weight neonates

Pediatric Infectious Disease Journal

Volumn 28, Issue 3, 2009, Pages 210-214

  Simmonds, Aryeh ^a,b   Munoz, Jose ^c   Aguero Rosenfeld, Maria ^c   Carbonaro, Carol ^c   Montecalvo, Marisa ^c   Clones, Barbara ^c   Lagamma, Edmund F ^d  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c Maria Fareri Children's Hospital   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Acinetobacter; Acinetobacter baumannii; Antibiotic resistance; Extremely low birth weight; Neonatal intensive care unit

Indexed keywords

CEFOTAXIME; COTRIMOXAZOLE; DOBUTAMINE; DOPAMINE; IMIPENEM; IMMUNOGLOBULIN; MEROPENEM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ARTICLE; BLOOD CULTURE; CLINICAL ARTICLE; EPIDEMIC; EXTREMELY LOW BIRTH WEIGHT; FATALITY; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; MALE; MEDICAL RECORD REVIEW; MULTIDRUG RESISTANCE; NEUTROPENIA; NEWBORN; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; ADULT; CLASSIFICATION; DRUG EFFECT; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PREMATURITY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTENSIVE CARE UNITS, NEONATAL; MALE;

EID: 63449087329     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31818cb0aa     Document Type: Article

References (23)

1. Al-Khoja MS, Darell JH. The skin as the source of Acinetobacter and Morax-ella species occurring in blood cultures. J Clin Pathol. 1979;32:497- 499.
2. Rosenthal S, Tager I. Prevalence of Gram-negative rods in the normal pharyngeal flora. Ann Intern Med. 1975;83:355-357.
3. Baltimore RS, Duncan RL, Schapiro ED, et al. Epidemiology of pharyngeal colonization of infants with aerobic Gram negative rod bacteria. J Clin Microbiol. 1989;27:91-95.
4. Munoz-Price L, Weinstein R. Acinetobacter infection. N Engl J Med. 2008;358:1271-1281.
5. Tilley P, Roberts F. Bacteremia with Acinetobacter species: risk factors and prognosis in different clinical settings. Clin Infect Dis. 1994;18: 896-900.
6. Allen D, Hartman B. Acinetobacter species. In: Mandell G, Bennett J, Dolin R, eds. Principles and Practices of Infectious Disease. 6th ed. Philadelphia, PA: Churchill Livingstone; 2005:2632-2635.
7. Qulae J, Bratu S, Landman D, et al. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin Infect Dis. 2003;37:214-220.
8. Wendt C, Dietze B, Dietz E, et al. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol. 1997;35:1394-1397.
9. Wisplinghoff H, Edmond MB, Pfaller MA, et al. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology and antimicrobial susceptibility. Clin Infect Dis. 2000;31:690-697.
10. Nagels B, Ritter E, Thomas B, et al. Acinetobacter baumannii colonization in ventilated preterm infants. Eur J Clin Microbiol Infect Dis. 1998;17:37-40.
11. McDonald L, Walker M, Carson L, et al. Outbreak of Acinetobacter spp. bloodstream infections in a nursery associated with contaminated aerosols and air conditioners. Pediatr Infect Dis J. 1998;17:716-722.
12. Pillay T, Pillay DG, Adhikari M, et al. An outbreak of neonatal infection with Acinetobacter linked to contaminated suction catheters. J Hosp Infect. 1999; 43:299 -304.
13. von Dolinger de Brito D, Oliveira EJ, Abdallah VO, et al. An outbreak of Acinetobacter baumannii septicemia in a neonatal intensive care unit of a university hospital in Brazil. Braz J Infect Dis. 2005;9:301-309.
14. Mittal N, Nair D, Gupta N, et al. Outbreak of Acinetobacter spp septicemia in a neonatal ICU. Southeast Asian J Trop Med Public Health. 2003;34:365-366.
15. Melamed R, Greenberg D, Porat N, et al. Successful control of an Acinetobacter baumannii outbreak in a neonatal intensive care unit. J Hosp Infect. 2003;53:31-38.
16. Huang Y, Su LH, Wu TL, et al. Outbreak of Acinetobacter baumannii bacteremia in a neonatal intensive care unit: clinical implications and genotyping analysis. Pediatr Infect Dis J. 2002;21:1105-1109.
17. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-2239.
18. Kocherlakota P, La Gamma EF. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia. Pediatrics. 1997;100:1- 6.
19. Simmonds A, LaGamma EF. NEC, part II: toward improving mucosal barrier defenses: rhG-CSF plus IgG antibody. Indian J Pediatr. 2006; 73:1019-1026.
20. Yoon J, Urban C, Terzian C, et al. In vitro double and triple synergistic activities of polymyxin b, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2004; 48:753-757.
21. Cartlidge P. The epidermal barrier. Semin Neonatol. 2000;5:273-280.
22. La Gamma E. Skin - The Ultimate Barrier, Strategies for Management of Micropreemies, MFCH-NICU House Staff Manual; 1995.
23. La Gamma EF, De Castro MH. What is the rationale for the use of granulocyte and granulocyte-macrophage colony-stimulating factors in the neonatal intensive care unit? Acta Paediatr Suppl. 2002;91:109 -116.